Corticosteroids are beneficial as treatment of certain @entity378 syndromes. We reviewed all cases of peritoneal @entity378 diagnosed at our institution over 10 years to evaluate the role of corticosteroid administration combined with antituberculous therapy. Nine @entity1 were treated with @entity230 plus antituberculosis agents (cases), and 26 received antituberculosis treatment only (controls). The two groups were not significantly different in terms of their basic demographics or disease. Nineteen controls compared with one case had recurrent @entity490 . Seven controls had 17 emergency department visits because of @entity490 . @entity1321 was diagnosed for five of these @entity1 , four of whom underwent laparotomy revealing extensive adhesions. Three controls died, and no case died. No case required laparotomy, had a diagnosis of @entity1321 , or visited the emergency department because of @entity490 . These findings suggest that @entity228 administration combined with antituberculosis treatment reduces the frequency of morbidity and complications in @entity1 with peritoneal @entity378 .

Corticosteroid treatment of peritoneal XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity228 :: ('CHEBI:50858', 'Chemical') :: ['corticosteroid'] @entity1321 :: ('MESH:D007415', 'Disease') :: ['intestinal obstruction', 'Intestinal obstruction'] @entity490 :: ('MESH:D015746', 'Disease') :: ['abdominal pain'] @entity230 :: ('MESH:D013256', 'Chemical') :: ['steroids'] @entity378 :: ('MESH:D014376', 'Disease') :: ['tuberculosis']
@entity378 :: (MESH:D014376,Disease) :: ['tuberculosis']
